chr18-21384325-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_001142966.3(GREB1L):c.277G>A(p.Glu93Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00415 in 1,551,744 control chromosomes in the GnomAD database, including 19 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0031 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 17 hom. )
Consequence
GREB1L
NM_001142966.3 missense
NM_001142966.3 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 9.14
Genes affected
GREB1L (HGNC:31042): (GREB1 like retinoic acid receptor coactivator) Acts upstream of or within kidney development. Predicted to be integral component of membrane. Implicated in autosomal dominant nonsyndromic deafness and renal agenesis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GREB1L. . Gene score misZ 5.3659 (greater than the threshold 3.09). Trascript score misZ 5.6738 (greater than threshold 3.09). GenCC has associacion of gene with bilateral renal agenesis, renal hypodysplasia/aplasia 3, renal agenesis, unilateral, hearing loss, autosomal dominant 80.
BP4
Computational evidence support a benign effect (MetaRNN=0.0039663613).
BP6
Variant 18-21384325-G-A is Benign according to our data. Variant chr18-21384325-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 917910.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00308 (469/152320) while in subpopulation NFE AF= 0.00501 (341/68030). AF 95% confidence interval is 0.00457. There are 2 homozygotes in gnomad4. There are 215 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 469 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GREB1L | NM_001142966.3 | c.277G>A | p.Glu93Lys | missense_variant | 4/33 | ENST00000424526.7 | NP_001136438.1 | |
LOC101927521 | XR_001753366.2 | n.245-3650C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GREB1L | ENST00000424526.7 | c.277G>A | p.Glu93Lys | missense_variant | 4/33 | 5 | NM_001142966.3 | ENSP00000412060 | ||
ENST00000584611.1 | n.289+3188C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00308 AC: 469AN: 152202Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
469
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00260 AC: 410AN: 157698Hom.: 0 AF XY: 0.00264 AC XY: 220AN XY: 83278
GnomAD3 exomes
AF:
AC:
410
AN:
157698
Hom.:
AF XY:
AC XY:
220
AN XY:
83278
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00427 AC: 5976AN: 1399424Hom.: 17 Cov.: 31 AF XY: 0.00414 AC XY: 2856AN XY: 690226
GnomAD4 exome
AF:
AC:
5976
AN:
1399424
Hom.:
Cov.:
31
AF XY:
AC XY:
2856
AN XY:
690226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00308 AC: 469AN: 152320Hom.: 2 Cov.: 32 AF XY: 0.00289 AC XY: 215AN XY: 74484
GnomAD4 genome
AF:
AC:
469
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
215
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
28
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
17
ExAC
AF:
AC:
52
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | GREB1L: PP2, BS1 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mayer-Rokitansky-Kuster-Hauser syndrome;C4540497:Renal hypodysplasia/aplasia 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Human Genetic Laboratory, University of Liege | Feb 20, 2020 | The variant is in a gene (GREB1L) previously associated with renal and uterine malformations in human.The variant is reported in Gnomad with a MAF:0.002813 and is reported once at a homozygous state. The variant affects a moderately conserved nucleotide and poorly conserved aminoacid. In silico prediction are conflicting. We have identified this heterozygous variant in one individual with MRKH syndrome type 1 (sequencing not performed in the parents); one individual with MRKH type 2, mild caliectasis, vertebral anomalies and imperforate anus (sequencing not performed in the parents); and in two fetuses with uterovaginal aplasia, bilateral renal agenesis, ureter and bladder agenesis as well as their asymptomatic father (in cis with the variant c.3970-20A>G in GREB1L). - |
GREB1L-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D;D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Uncertain
D;D;.
Sift4G
Uncertain
D;D;D
Polyphen
P;.;P
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at